CiteFacts · FDA Drug Shortages · FDA source
Amino Acid Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| B. Braun Medical Inc. | Plenamine, Injection, 0.15 (NDC 0264-4500-00) | Available | 08/07/2026 |
| B. Braun Medical Inc. | Plenamine, Injection, 0.15 (NDC 0264-4500-05) | Available | 08/07/2026 |
| B. Braun Medical Inc. | TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10) | Available | 08/07/2026 |
| Baxter Healthcare | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03) | Available | 08/17/2026 |
| Baxter Healthcare | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06) | Available | 08/17/2026 |
| Baxter Healthcare | PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL; 2.06 g/100 mL; 1.18 g/100 mL; 1.08 g/100 mL; 1.08 g/100 mL; 1.35 g/100 mL; 760 mg/100 mL; 1 g/100 mL; 1.34 g/100 mL; 1.02 g/100 mL; 980 mg/100 mL; 320 mg/100 mL; 50 mg/100 mL; 1.44 g/100 mL (NDC 0338-0499-06) | Available | 08/17/2026 |
| Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03) | Available | 08/17/2026 |
| Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04) | Available | 08/17/2026 |
| Baxter Healthcare | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06) | Available | 08/17/2026 |
| Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-03) | Unavailable | 08/17/2026 |
| Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-04) | Available | 08/17/2026 |
| Baxter Healthcare | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-06) | Available | 08/17/2026 |
| Otsuka ICU Medical LLC | Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17) | Available | 08/17/2026 |
| Otsuka ICU Medical LLC | Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17) | Available | 08/17/2026 |
| Otsuka ICU Medical LLC | Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05) | Unavailable | 08/17/2026 |
| Otsuka ICU Medical LLC | Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03) | Unavailable | 08/17/2026 |
Source facts
Grouped generic ingredient: Amino Acid Injection · 16 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Gastroenterology
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.